Making a Meaningful Difference for Professors and Peers
Patient-led research initiatives in the Netherlands are currently accelerating the development of neuroprotective therapies for Amyotrophic Lateral Sclerosis (ALS). By bypassing traditional funding bottlenecks, these collaborations between patients and clinicians ... Read More